Pregnancy and Neonatal Outcomes Following Antenatal Exposure to Raltegravir: a Pooled Analysis From the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC)
Condition: HIV Infections Intervention: Drug: Raltegravir Sponsors: Fondazione Penta UK; UCL Great Ormond Street Institute of Child Health Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 2, 2023 Category: Research Source Type: clinical trials
HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label
Condition: HIV Infections Intervention: Drug: DORAVIRINE 100 MG [Pifeltro] Sponsor: Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2020 Category: Research Source Type: clinical trials
Phase II Trial Evaluating the Capacity of the Dual Combination Doravirine/Raltegravir in HIV-1 Infected Patients Under a Current Antiretroviral Regimen
Condition: HIV Infections Intervention: Drug: DORAVIRINE 100 MG [Pifeltro] Sponsor: Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2020 Category: Research Source Type: clinical trials
